Skip to content
★ Sign in to follow
SC

Stem Cell Innovations, Inc. Stock: price and insider trades · United States

Stem Cell Innovations, Inc.: what insiders have been doing

Every trade that managers of Stem Cell Innovations, Inc. disclose to SEC (Form 4) is tracked on this page. No insider at Stem Cell Innovations, Inc. has published a filing in the past twelve months. The most recent one dates from 4 March 2008.

Our records for Stem Cell Innovations, Inc. go back to 2006, with no purchases and 12 sales on the open market in total.

These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Insider Decl.
17
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€80,217
12 ops. · all time

Financial data

· cache

Last declaration on 4 March 2008
Declarations17 total
  • ▼
    Chief Executive OfficerExecutives
    8,384 USD0SEC
    640,000 shares@ US$0.0131COMMON STOCK, PAR VALUE $.01 PER SHARESEC:0001019056-08-000362:0
  • ▼
    Chief Executive OfficerExecutives
    1,438 USD0SEC
    115,000 shares@ US$0.0125COMMON STOCK, PAR VALUE $.01 PER SHARESEC:0001019056-08-000362:1
  • ▼
    Chief Executive OfficerExecutives
    2,500 USD0SEC
    200,000 shares@ US$0.0125COMMON STOCK, PAR VALUE $.01 PER SHARESEC:0001019056-08-000362:2
  • ▼
    Chief Executive OfficerExecutives
    1,705 USD0SEC
    155,000 shares@ US$0.011COMMON STOCK, PAR VALUE $.01 PER SHARESEC:0001019056-08-000362:3
  • ▼
    Chief Executive OfficerExecutives
    2,750 USD0SEC
    250,000 shares@ US$0.011COMMON STOCK, PAR VALUE $.01 PER SHARESEC:0001019056-08-000362:4
  • ▼
    Chief Executive OfficerExecutives
    1,980 USD0SEC
    180,000 shares@ US$0.011COMMON STOCK, PAR VALUE $.01 PER SHARESEC:0001019056-08-000362:5
  • ▼
    Chief Executive OfficerExecutives
    1,735 USD0SEC
    173,486 shares@ US$0.01COMMON STOCK, PAR VALUE $.01 PER SHARESEC:0001019056-08-000362:6
  • ▼
    Chief Executive OfficerExecutives
    5,419 USD0SEC
    541,881 shares@ US$0.01COMMON STOCK, PAR VALUE $.01 PER SHARESEC:0001019056-08-000362:7
  • ▼
    Chief Executive OfficerExecutives
    4,000 USD0SEC
    400,000 shares@ US$0.01COMMON STOCK, PAR VALUE $.01 PER SHARESEC:0001019056-08-000362:8
  • ▼
    Chief Executive OfficerExecutives
    90,200 USD0SEC
    8,200,000 shares@ US$0.011COMMON STOCK, PAR VALUE $.01 PER SHARESEC:0001019056-08-000362:9
  • ▼
    Chief Executive OfficerExecutives
    580 USD0SEC
    44,633 shares@ US$0.013COMMON STOCK, PAR VALUE $.01 PER SHARESEC:0001019056-08-000362:10
  • ●
    10% OwnerExecutives
    0SEC
    10,638,262 shares0Common StockSEC:0001005477-07-001980:0
  • ●
    10% OwnerExecutives
    0SEC
    10,000,000 shares0Common StockSEC:0001005477-07-001980:1
  • ▼
    10% OwnerExecutives
    0SEC
    10,000,000 sharesCommon StockSEC:0001005477-07-001980:2
  • ●
    10% OwnerExecutives
    0SEC
    1,032,601 sharesCommon StockSEC:0001005477-06-002405:0
  • ●
    10% OwnerExecutives
    0SEC
    3,210,197 sharesCommon StockSEC:0001005477-06-002405:1
  • ●
    10% OwnerExecutives
    0SEC
    118,940 sharesCommon StockSEC:0001005477-06-002405:2

17 of 17 declarations

About Stem Cell Innovations, Inc.

Stem Cell Innovations, Inc. is a company focused on developing therapies based on stem cells. It is listed on the XNAS market.